Synlogic (NASDAQ:SYBX) Shares Pass Below 50-Day Moving Average – Here’s What Happened

Synlogic, Inc. (NASDAQ:SYBX) passed below its 50-day moving average during trading on Tuesday . The stock has a 50-day moving average of $1.37 and traded as low as $1.26. Synlogic shares last traded at $1.31, with a volume of 3,567 shares.

Synlogic Stock Performance

The stock has a fifty day moving average of $1.36 and a 200 day moving average of $1.41. The company has a market capitalization of $15.20 million, a PE ratio of -0.31 and a beta of 0.72.

Synlogic (NASDAQ:SYBX) last issued its quarterly earnings data on Thursday, March 6th. The biotechnology company reported ($0.06) earnings per share (EPS) for the quarter, topping the consensus estimate of ($0.10) by $0.04. As a group, equities analysts predict that Synlogic, Inc. will post -2.71 EPS for the current year.

Synlogic Company Profile

Synlogic, Inc, a clinical-stage biopharmaceutical company, engages in the discovery and development of synthetic biotics to treat metabolic diseases in the United States. Its pipeline include SYNB1618, an orally administered, non-systemically absorbed drug candidate to treat phenylketonuria; SYNB1934, an orally administered, non-systemically absorbed drug candidate, which is in Phase III clinical trial to treat phenylketonuria; SYNB1353, an orally administered, non-systemically absorbed drug candidate, which is in Phase I clinical to treat homocystinuria; SYNB8802, an orally administered, non-systemically absorbed drug candidate that is in Phase II clinical trial for the treatment of enteric hyperoxaluria; and SYNB2081 to lower uric acid for the potential treatment of gout.